Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.
Awesome. The action of a sentiment bombed stock! Yay.
50p Monday to 200p Friday? Que?
CO is clearly not invested.
Pathetic LSE filtering.
https://www . vox markets . co . uk/articles/traders-cafe-with-zak-mir-mark-epstein-ceo-mobile-streams-9288cd8/
https://www . ********** . co . uk/articles/traders-cafe-with-zak-mir-mark-epstein-ceo-mobile-streams-9288cd8/
Yes, it's hear, and worth a listen https://www.**********.co.uk/articles/traders-cafe-with-zak-mir-mark-epstein-ceo-mobile-streams-9288cd8/
Yeah, I don't bother with CO's stuff. IMHO, the only way is up for MOS right now. DYOR of course.
Why the downdraft? I'd have thought holders would be holding here now?!
Staylong - indeed, and my hands are white as I have been sat on them for so long, my avg is sadly well over 2x today's price, for sure I'd like your hopes to be true and make an excellent return on today's price. I might just claw back some of my paper loss before I bail out! Aaggh.
...I've got into the habit about saying nothing at all about this or most of the other sad excuses for shareholdings in my PF to my other half. Next year Rodders...
....indeed, it seems lots of peeps have lots of manufacturing capacity. We are not being told the extent to which said capacity is being filled.
Ha ha. Boil away!
AS is sounding very bullish re AVA6K. Then again, he's been bullish about a certain something else in the past!
Wiggly, it is possible to say that near term AVA6000 is a better value driver, if the LFT drivers are bu**er all. I guess.
...need that £2 please, my avg is a long way towards that from where we are now. The bottom draw is getting dusty.
HUA is coming:
"The regulatory approval of a self-test version of the AffiDX® SARS-CoV-2 antigen lateral flow test is a critical milestone because self-administered testing represents a significantly larger commercial opportunity than professional use testing. Avacta is working closely with its partner Medusa19 to support Medusa19's application for a CE mark for an AffiDX® SARS-CoV-2 antigen self-test. Good progress is being made in this regard with the submission of the regulatory documentation to a notified body in Europe. Medusa19 and Avacta are currently awaiting the response of the notified body and will update the market when a response is received."
Goolang, right, so you are positive about this share then, great to read your upbeat assessment.....
...would prefer the shot to be in the goal and not at the goal post.
I see FB being mentioned - I've lost the plot temporarily, I hope....
If you folks are not here, is there anyone talking about NGHT anywhere else e.g. on telegram?